Main page > Page not found
ESC Congress 2012
Date: 25-29 August 2012
Place: Munich, Germany
Ai Mediq S.A. is pleased to announce that it is participating in the European Society of Cardiology (ESC) Congress.
This gathering will be a platform to present updated reports on clinic manuals, publicise the most recent research findings and discuss the most vital cardiovascular issues. Our goal at the ESC Congress is to enhance our productive relations with national cardiology associations, establish working ties with societies from Eastern Europe and present a new method of non-pharmaceutical therapy for cardiovascular and bronchopulmonary diseases - ReOxy®.
ReOxy® is a device for controlled interval normobaric hypoxic-hyperoxic therapy based on SRT® (Self Regulated Treatment). Biofeedback automatically adjusts the procedure parameters (duration of hypoxia and oxygenation intervals) in response to alterations in pulse oximeter readouts during the whole procedure. The use of this device has the following registered physiological effects: more effective oxygen utilization (better capacity of the tissues to extract and utilise oxygen from blood with low concentrations) and higher tissue resistance to hypoxia (reduced need for oxygen and energy).
Please visit our stand B104 to obtain more information about ReOxy®.